News | May 16, 2024
Cipla invests additional Rs. 26 crore in Achira
Achira is engaged in development and commercialization of PoC medical test kits in India
Achira is engaged in development and commercialization of PoC medical test kits in India
Collaboration to leverage AbbVie's psychiatry expertise and Gilgamesh's innovative research platform to develop next-generation neuroplastogens for the treatment of psychiatric disorders
Data showed that the primary endpoint of recurrence-free survival (RFS) met the pre-specified futility criteria
Sevelamer Carbonate Tablets approval consolidates the company's position in the Sevelamer segment
Neuland Laboratories has reported total income of Rs. 390.36 crores during the period ended March 31, 2024
The company has posted net profit of Rs. 4,121.55 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024
The company is committed to address this observation comprehensively within stipulated time
The product is used to treat amyotrophic lateral sclerosis
Ashland's nutraceuticals business supplies a broad portfolio of active ingredients and formulation aids to nutritional product companies
Subscribe To Our Newsletter & Stay Updated
